Lack of Antiparkinsonian Effects of Systemic Injections of the Specific T-type Calcium Channel Blocker ML218 in MPTP-Treated Monkeys

Dopaminergic medications ameliorate many of the motor impairments of Parkinson’s disease (PD). However, parkinsonism is often only partially reversed by these drugs, and they can have significant side effects. Therefore, a need remains for novel treatments of parkinsonism. Studies in rodents and pre...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:ACS Chem Neurosci
Hlavní autoři: Galvan, Adriana, Devergnas, Annaelle, Pittard, Damien, Masilamoni, Gunasingh, Vuong, Jocelyn, Daniels, J. Scott, Lindsley, Craig W., Morrison, Ryan D., Wichmann, Thomas
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5510653/
https://ncbi.nlm.nih.gov/pubmed/27596273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acschemneuro.6b00186
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky